FDA Should Rethink Its Definition Of A High-Risk Device, Say Patient Advocates
This article was originally published in The Gray Sheet
Executive Summary
Patient and consumer groups urged FDA to rethink its current stance on what constitutes a high-risk device at a meeting on the 510(k) program last week.